This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Ehrlichia canis Gp19, N-His
Product Overview
BioVenic's Recombinant Ehrlichia canis Gp19, N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 21.4 kDa. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Ehrlichia canis Gp19 is a major immunoreactive glycoprotein of approximately 19kDa in Ehrlichia canis. It is highly conserved and elicits an early Ehrlichia-specific antibody response in infected dogs. The protein contains an N-terminal region rich in serine/threonine/glutamate (STE) that includes a dog-specific antibody epitope and reacts strongly with serum from E. canis-infected dogs. Gp19 is expressed on both reticulate and dense-cored cells of Ehrlichia canis and is found extracellularly in the fibrillar matrix and associated with the morula membrane, as well as in the host cell cytoplasm and nucleus. Due to its high conservation and immunoreactivity, Gp19 is considered a potential target for diagnostic and vaccine development.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.